Teva Pharmaceuticals USA Inc recalls Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%, Antihistamine

Recalled March 22, 2023 · FDA recall D-0469-2023 · Teva Pharmaceuticals USA

Hazard

Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity. · FDA Class II

Units

715,632 bottles

Sold at

Nationwide in the U.S.A.

Description

Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity.

Product

Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%, Antihistamine, 2.5 mL (0.085 fl oz) bottle, Sterile, Distributed by Medtech Products Inc. Tarrytown, NY 10591, A Prestige Consumer Healthcare company, Made in Israel, UPC 678112000708; NDC 67172-504-01.

Manufacturer(s)

Teva Pharmaceuticals USA Inc

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →